USPTO 2015–2025 USPTO PatentsView US Corporation

Deep Science, LLC

USPTO PatentsView assignee record - 39 granted patents across 62 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Deep ranks #8,185 of 49,997 tracked US assignees by granted-patent volume, with 39 patents across 62 technology areas.

#8,185
of 49,997 US assignees by volume
Top 2%
by Innovation Score (63.4/100)
26.8
avg claims per patent
-56%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8185 · US Corporation #8,185 · 39 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 39 grants
  • UPPER-Q #8,185/49,997
  • PHOTO-FINISH CyDex Pharmaceuticals
  • CPC-WIDE A61B · 62 areas
  • INNOV-STRONG 63.4/100
  • CLAIMS-DENSE 26.8 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -56% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: CyDex Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Deep

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Deep's Innovation Score is 63.4/100 (top 2% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Deep's grant cadence moved

Between 2020–2024, Deep Science, LLC received 12 grants versus 27 in 2015–2019 (-56% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2016 at 13 grants and bottomed in 2019 at 1. Lead class A61B accounts for 15.4% of the portfolio across 62 subclasses. Volume neighbours: CyDex Pharmaceuticals, Inc. (#8,184) and Espressif Systems (SHANGHAI) Co., Ltd. (#8,192).

Deep's three-year grant acceleration

Deep Science, LLC shows 8 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Deep's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Deep holds 39 patents at rank #8,188, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Deep

By rank, the assignees closest to #8,188 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Deep's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Deep, neither rank-band nor same-CPC leaders (those blocks stay above).

Deep's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

63 Top 2% higher than 98% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 201620172018201920202021202220232024 2
USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Deep Science, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 13 33.3%
2017 10 25.6%
2018 3 7.7%
2019 1 2.6%
2020 3 7.7%
2021 1 2.6%
2022 5 12.8%
2023 1 2.6%
2024 2 5.1%

Which technologies does Deep Science, LLC patent most?

Top 15 of 62 technology areas

Where it ranks

Overall rank by patents

#8,185

of 49,997 tracked assignees

Innovation Score

63.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Deep Science, LLC's patent record in context - here's where to go next.

  • Deep Science, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 15.4% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #8,185 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Deep Science, LLC against CyDex Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 63.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.